SOUTH SAN FRANCISCO, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the upcoming Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 15, 2011 at 10:30 A.M. Eastern Time at The Pierre Hotel in New York City.
